to put into context the heroics NNLX's double doct
Post# of 9122
whereas the NIH process is not identical,there is similar heavy competition and strict "grading',which often involves back and forth between the applicant and NIH,with many applications rejected the first time
last part of another companies(source cited above) July 24 PR
"The Company routinely receives official correspondence related to its pending patent applications from Canadian and US Patent and Trademark Offices. Such correspondence requires a formal response from the Company to refine the application to address any objections raised by the offices. Such official correspondence can be expected by the Company as it is normal for patents to be initially refused (even a few times) by the patent office. The Company is entitled to submit arguments and/or amend its claims in order to address the Examiner’s reasons for rejection to secure grant of a patent. As usual, Company patent lawyers review the merits of the Patent Office’s comments and prepare and file responses as required."